Please login to the form below

Not currently logged in
Email:
Password:

Venclyxto

This page shows the latest Venclyxto news and features for those working in and with pharma, biotech and healthcare.

AbbVie and Roche plan Venclexta combo filings in leukaemia

AbbVie and Roche plan Venclexta combo filings in leukaemia

AbbVie and Roche's long-anticipated combination trial of Venclexta/Venclyxto and Rituxan in chronic lymphocytic leukaemia, setting up regulatory filings for the duo.

Latest news

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics